U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Guthrie B, Rogers G, Livingstone S, et al. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Southampton (UK): National Institute for Health and Care Research; 2024 Feb. (Health and Social Care Delivery Research, No. 12.04.)

Cover of The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis

The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.

Show details

Appendix 5Direct treatment disutility elicitation: supplementary results

TABLE 46

TABLE 46

Count data (normalised) for best and worst scores

FIGURE 34. Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: statins.
FIGURE 34. Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: statins.

FIGURE 34

Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: statins. (a) No inconvenience; (b) inconvenience; (c) MSE 1%; (d) MSE 5%; (e) MSE 9%; (f) MSE 13%; (g) SSE 0.1%; (h) SSE 0.3%; (i) SSE 0.5%; and (j) SSE 0.7%.

FIGURE 35. Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: bisphosphonates.
FIGURE 35. Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: bisphosphonates.
FIGURE 35. Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: bisphosphonates.

FIGURE 35

Kernel density plots showing distribution of BWS responses stratified by question context and respondent type: bisphosphonates. (a) No inconvenience; (b) inconvenience; (c) MSE 1%; (d) MSE 5%; (e) MSE 9%; (f) MSE 13%; (g) SSE 0.1%; (h) SSE 0.3%; (i) SSE 0.5%; and (j) SSE 0.7%.

Copyright © 2024 Guthrie et al.

This work was produced by Guthrie et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

Bookshelf ID: NBK601051
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (9.3M)

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...